Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions - PubMed (original) (raw)
. 1997 Aug 1;57(15):3305-13.
Affiliations
- PMID: 9242465
Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions
T Nakamura et al. Cancer Res. 1997.
Abstract
Invasive and metastatic potentials of several types of carcinoma cells are regulated through interactions with host stromal cells, e.g., tumor-stromal interactions. Because hepatocyte growth factor (HGF), a ligand for the c-Met proto-oncogene product, is a mesenchymal- or stromal-derived factor that induces mitogenic, motogenic, and morphogenic responses, we examined the mechanisms involved in tumor-stromal interactions in vitro. The c-Met/HGF receptor was expressed in A431 human epidermoid carcinoma cells, A549 human non-small cell lung cancer cells, HuCC-T1 human cholangiocellular carcinoma cells, and SBC-3 human small cell lung carcinoma cells. HGF stimulated cell growth, scattering, and invasion of these cells. Although these cells did not produce biologically significant levels of HGF, these cells did secrete soluble factors that potently stimulated HGF production in human skin fibroblasts. These carcinoma cell-derived HGF inducers proved to be interleukin-1 (IL-1) in A431 cells, IL-1 plus basic fibroblast growth factor (bFGF) in A549 and HuCC-T1 cells, and bFGF plus platelet-derived growth factor in SBC-3 cells. When these carcinoma cells were cocultured with fibroblasts, HGF levels in the coculture system were much higher than the levels in fibroblasts alone, without cocultured carcinoma cells. Together with the increase in HGF levels, the number of invasive cells increased, but in vitro invasion of carcinoma cells in the coculture system was strongly inhibited by anti-HGF antibodies. Thus, there are mutual interactions between carcinoma cells and fibroblasts: IL-1, bFGF, and platelet-derived growth factor derived from tumor cells play a role in inducing HGF expression in stromal fibroblasts, whereas fibroblast-derived HGF, in turn, leads to invasive growth in carcinoma cells. The mutual interactions, as mediated by HGF and HGF inducers, may play a significant role in the occurrence of invasion and metastasis of carcinoma cells.
Similar articles
- Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts.
Matsumoto-Taniura N, Matsumoto K, Nakamura T. Matsumoto-Taniura N, et al. Br J Cancer. 1999 Sep;81(2):194-202. doi: 10.1038/sj.bjc.6690677. Br J Cancer. 1999. PMID: 10496342 Free PMC article. - Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line.
Hasina R, Matsumoto K, Matsumoto-Taniura N, Kato I, Sakuda M, Nakamura T. Hasina R, et al. Br J Cancer. 1999 Aug;80(11):1708-17. doi: 10.1038/sj.bjc.6690587. Br J Cancer. 1999. PMID: 10468286 Free PMC article. - Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.
Neaud V, Faouzi S, Guirouilh J, Le Bail B, Balabaud C, Bioulac-Sage P, Rosenbaum J. Neaud V, et al. Hepatology. 1997 Dec;26(6):1458-66. doi: 10.1053/jhep.1997.v26.pm0009397985. Hepatology. 1997. PMID: 9397985 - Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
Matsumoto K, Nakamura T, Sakai K, Nakamura T. Matsumoto K, et al. Proteomics. 2008 Aug;8(16):3360-70. doi: 10.1002/pmic.200800156. Proteomics. 2008. PMID: 18646008 Review. - Molecular characteristics of HGF-SF and its role in cell motility and invasion.
Weidner KM, Hartmann G, Naldini L, Comoglio PM, Sachs M, Fonatsch C, Rieder H, Birchmeier W. Weidner KM, et al. EXS. 1993;65:311-28. EXS. 1993. PMID: 8380739 Review.
Cited by
- Reduction in Hepatocyte Growth Factor Serum Levels is Associated with Improved Prognosis in Advanced Lung Adenocarcinoma Patients Treated with Afatinib: a Phase II Trial.
Arrieta O, Cruz-Rico G, Soto-Perez-de-Celis E, Ramírez-Tirado LA, Caballe-Perez E, Martínez-Hernández JN, Martinez-Alvarez I, Soca-Chafre G, Macedo-Pérez EO, Astudillo-de la Vega H. Arrieta O, et al. Target Oncol. 2016 Oct;11(5):619-629. doi: 10.1007/s11523-016-0425-x. Target Oncol. 2016. PMID: 27033062 Clinical Trial. - NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells.
Maehara N, Matsumoto K, Kuba K, Mizumoto K, Tanaka M, Nakamura T. Maehara N, et al. Br J Cancer. 2001 Mar 23;84(6):864-73. doi: 10.1054/bjoc.2000.1682. Br J Cancer. 2001. PMID: 11259105 Free PMC article. - Breast cancer cells induce cancer-associated fibroblasts to secrete hepatocyte growth factor to enhance breast tumorigenesis.
Tyan SW, Kuo WH, Huang CK, Pan CC, Shew JY, Chang KJ, Lee EY, Lee WH. Tyan SW, et al. PLoS One. 2011 Jan 13;6(1):e15313. doi: 10.1371/journal.pone.0015313. PLoS One. 2011. PMID: 21249190 Free PMC article. - Influence of mTOR-inhibitors and mycophenolic acid on human cholangiocellular carcinoma and cancer associated fibroblasts.
Heits N, Heinze T, Bernsmeier A, Kerber J, Hauser C, Becker T, Kalthoff H, Egberts JH, Braun F. Heits N, et al. BMC Cancer. 2016 May 20;16:322. doi: 10.1186/s12885-016-2360-8. BMC Cancer. 2016. PMID: 27206490 Free PMC article. - Feedback Regulation in a Cancer Stem Cell Model can Cause an Allee Effect.
Konstorum A, Hillen T, Lowengrub J. Konstorum A, et al. Bull Math Biol. 2016 Apr;78(4):754-785. doi: 10.1007/s11538-016-0161-5. Epub 2016 Apr 25. Bull Math Biol. 2016. PMID: 27113934 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous